Mankind Pharma Ltd (MANKIND) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 1003845, "name": "Mankind Pharma", "stock_name": "Mankind Pharma", "full_name": "Mankind Pharma Ltd", "name_url": "stocks-analysis/mankind-pharma", "exchange": 1, "exchangecode": "", "country_id": 34, "currency": "INR", "cmp": "2,162.60", "chg": 98.8, "chgp": "4.79%", "dir": 1, "prev_price": "2,063.80", "mcapval": "87,785.00 Cr", "mcap": "Large Cap", "scripcode": 543904, "symbol": "MANKIND", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "", "isin": "INE634S01028", "curr_date": "Feb 03", "curr_time": "", "bse_nse_vol": "7.93 lacs", "exc_status": "Active", "traded_date": "Feb 03, 2026", "traded_date_str": "2026 02 03", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/mankind-pharma-1003845-1&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Mankind Pharma Sees Sharp Open Interest Surge Amid Mixed Technical Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-sees-sharp-open-interest-surge-amid-mixed-technical-signals-3818737", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/MankindPharmaLt_oi_spurts_by_underlying_3818737.png", "date": "2026-02-03 15:00:21", "description": "Mankind Pharma Ltd has witnessed a significant 26.3% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a strong intraday performance and outperformance relative to its sector, the stock faces mixed technical indicators and a recent downgrade in its mojo rating, prompting a nuanced outlook for traders and investors alike." }, { "title": "Mankind Pharma Sees Sharp Open Interest Surge Amid Bullish Derivatives Activity", "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-sees-sharp-open-interest-surge-amid-bullish-derivatives-activity-3818679", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/MankindPharmaLt_oi_spurts_by_underlying_3818679.png", "date": "2026-02-03 14:00:33", "description": "Mankind Pharma Ltd (MANKIND) witnessed a significant 17.5% increase in open interest in its derivatives segment on 3 Feb 2026, signalling heightened market interest and potential directional bets. The stock outperformed its sector and broader indices, supported by a notable volume surge and positive price action, despite mixed moving average signals and declining delivery volumes." }, { "title": "Mankind Pharma Ltd Hits Intraday High with 3.93% Surge on 3 Feb 2026", "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-ltd-hits-intraday-high-with-393-surge-on-3-feb-2026-3818445", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/MankindPharmaLt_priceRelatedfactors_3818445.png", "date": "2026-02-03 11:07:40", "description": "Mankind Pharma Ltd demonstrated robust intraday performance on 3 Feb 2026, surging to an intraday high of Rs 2,152.5, marking a 4.13% increase from the previous close. The stock outpaced its sector and broader market indices, reflecting notable trading momentum amid a mixed market backdrop." }, { "title": "Mankind Pharma Ltd Stock Hits 52-Week Low Amidst Continued Downtrend", "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-ltd-stock-hits-52-week-low-amidst-continued-downtrend-3816546", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/MankindPharmaLt_priceRelatedfactors_3816546.png", "date": "2026-02-02 11:46:31", "description": "Mankind Pharma Ltd’s shares declined to a fresh 52-week low of Rs.2053 today, marking a significant milestone in the stock’s recent performance. This new low reflects ongoing pressures on the company’s valuation amid subdued profit growth and valuation concerns within the Pharmaceuticals & Biotechnology sector." }, { "title": "Mankind Pharma Gains 1.05%: 2 Key Factors Driving the Week’s Movement", "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-gains-105-2-key-factors-driving-the-weeks-movement-3812382", "imagepath": "", "date": "2026-01-31 10:04:01", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>Jan 27:</strong> New 52-week low at Rs.2,060</p>\n <p><strong>Jan 28:</strong> Sharp surge in open interest amid mixed technical signals</p>\n <p><strong>Jan 30:</strong> Week closes at Rs.2,124.90 (+1.05%)</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.2,102.75</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.2,124.90</div><div class=\"stat-change positive\">+1.05%</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week..." }, { "title": "Mankind Pharma Sees Sharp Open Interest Surge Amid Mixed Technical Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-sees-sharp-open-interest-surge-amid-mixed-technical-signals-3807946", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/MankindPharmaLt_oi_spurts_by_underlying_3807946.png", "date": "2026-01-28 15:00:31", "description": "Mankind Pharma Ltd has witnessed a notable 10.75% increase in open interest in its derivatives segment, signalling heightened market activity despite the stock trading near its 52-week low. This surge in open interest, coupled with volume patterns and price movements, offers insights into evolving market positioning and potential directional bets among investors." }, { "title": "Mankind Pharma Ltd Stock Falls to 52-Week Low of Rs.2060", "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-ltd-stock-falls-to-52-week-low-of-rs2060-3805809", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/MankindPharmaLt_priceRelatedfactors_3805809.png", "date": "2026-01-27 10:49:40", "description": "Mankind Pharma Ltd’s shares declined to a fresh 52-week low of Rs.2060 on 27 Jan 2026, marking a significant price level amid a broader market downturn. The stock has underperformed its sector and key indices, reflecting a combination of subdued financial results and valuation concerns." }, { "title": "Mankind Pharma Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/mankind-pharma-ltd-is-rated-sell-3805292", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/MankindPharmaLt_mojoScore_3805292.png", "date": "2026-01-27 10:10:35", "description": "Mankind Pharma Ltd is rated Sell by MarketsMOJO, with this rating last updated on 19 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 27 January 2026, providing investors with the latest insights into the company’s performance and outlook." }, { "title": "Mankind Pharma Ltd Falls 3.37%: 4 Key Factors Driving This Week’s Decline", "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-ltd-falls-337-4-key-factors-driving-this-weeks-decline-3802899", "imagepath": "", "date": "2026-01-24 10:04:13", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>19 Jan:</strong> Bearish momentum confirmed amid technical downturn</p>\n <p><strong>20 Jan:</strong> Stock hits 52-week low at Rs.2,087.55</p>\n <p><strong>21 Jan:</strong> Further 52-week low at Rs.2,081.80 despite Sensex rebound</p>\n <p><strong>22 Jan:</strong> Significant open interest surge amid mixed market signals</p>\n <p><strong>23 Jan:</strong> Week closes at Rs.2,102.75, down 2.10% on the day</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.2,117.85</div></div>\n ..." } ], "total": 454, "sid": "1003845", "stock_news_url": "https://www.marketsmojo.com/news/mankind-pharma-1003845" }, "announcements": "", "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "", "data": [ { "title": "BOARD MEETING", "txt": "(03 Feb 2026)" } ] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Mankind Pharma Ltd has declared <strong>100%</strong> dividend, ex-date: 08 Aug 25", "dt": "2025-08-08", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

Jan 27: New 52-week low at Rs.2,060

Jan 28: Sharp surge in open interest amid mixed technical signals

Jan 30: Week closes at Rs.2,124.90 (+1.05%)

Read full news article

Mankind Pharma Sees Sharp Open Interest Surge Amid Mixed Technical Signals

2026-01-28 15:00:31

Mankind Pharma Ltd has witnessed a notable 10.75% increase in open interest in its derivatives segment, signalling heightened market activity despite the stock trading near its 52-week low. This surge in open interest, coupled with volume patterns and price movements, offers insights into evolving market positioning and potential directional bets among investors.

Read full news article

Mankind Pharma Ltd Stock Falls to 52-Week Low of Rs.2060

2026-01-27 10:49:40

Mankind Pharma Ltd’s shares declined to a fresh 52-week low of Rs.2060 on 27 Jan 2026, marking a significant price level amid a broader market downturn. The stock has underperformed its sector and key indices, reflecting a combination of subdued financial results and valuation concerns.

Read full news article

Mankind Pharma Ltd is Rated Sell

2026-01-27 10:10:35

Mankind Pharma Ltd is rated Sell by MarketsMOJO, with this rating last updated on 19 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 27 January 2026, providing investors with the latest insights into the company’s performance and outlook.